Foto del docente

Pier Paolo Piccaluga

Associate Professor

Department of Medical and Surgical Sciences

Academic discipline: MED/08 Pathology


Piccaluga, Pier Paolo; Martinelli, Giovanni; Rondoni, Michela; Malagola, Michele; Ronconi, Sonia; Visani, Giuseppe; Baccarani, Michele, Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly, «HAEMATOLOGICA», 2004, 88, pp. ECR37 - 37 [Scientific article]Open Access

MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M., Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely., «HAEMATOLOGICA», 2004, 89, pp. 495 - 497 [Scientific article]

VISANI G; ISIDORI A; GRAFONE T; TOSI P; SANTINI V; MALAGOLA M; MARTINELLI G.; PICCALUGA PP; GRAZIEV D; OTTAVIANI E; SPARAVENTI G; TURA S., No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?, «LEUKEMIA & LYMPHOMA», 2004, 45(7), pp. 1361 - 1364 [Scientific article]

Pileri S.A.; Piccaluga P.P.; Agostinelli C.; Sabattini E.; Bacci F.; Orduz R.; Righi S.; Sandri F.; Falini B.; Zinzani P.L.; Gallamini A.; Dalla Favera R., Peripheral T-cell lymphoma. A still uncurable disease?, in: Ten Years After the REAL Classification: Open Issues, «HAEMATOLOGICA», 2004, 89 (suppl 9), pp. 62 - 65 (atti di: Ten Years After the REAL Classification: Open Issues, Bologna, Italia, October 6–9, 2004.) [Contribution to conference proceedings]

PICCALUGA PP; RICCI P; MARTINELLI G.; MALAGOLA M; RONDONI M; VISANI G., Prompt resolution of nasal aspergillosis with intranasal instillation of liposomal amphotericin-B (amBisome) and granulocyte transfusions, «LEUKEMIA & LYMPHOMA», 2004, 45(3), pp. 637 - 638 [Scientific article]

MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M., Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission, «HAEMATOLOGICA», 2004, 89, pp. 85 - 86 [Scientific article]Open Access

PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M.; MARTINELLI G., The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients., «HAEMATOLOGICA», 2004, 80, pp. 1269 - 1271 [Scientific article]

Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifazi F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G., Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8], «LEUKEMIA», 2003, 17, pp. 650 - 652 [Scientific article]

Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccaluga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G., Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC, «CLINICAL CHEMISTRY», 2003, 49, pp. 1642 - 1650 [Scientific article]

Martinelli G.; Ottaviani E.; Buonomici S.; Isidori A.; Malagola M.; Piccaluga P.; Baccarani M., Two more inv(16) acute myeloid leukemia cases with infrequent CBFβ-MYH11 fusion transcript: Clinical and molecular findings [4], «HAEMATOLOGICA», 2002, 87, pp. 554 - 555 [Scientific article]